Trumplinked Stock Trades Spark Scrutiny Over Potential Conflicts Bloom Energy Surges on 26 Billion AI Infrastructure Partnership with Nebius Inflation Pressures Widen Beyond Oil and Iran Housing Food and Services Show Price Acceleration Micron Stock Reaches Milestone as UBS Highlights Strong Memory Chip Demand and Enhanced LongTerm Agreements Morning Market Roundup Microns Milestone Dicks Earnings and Paxtons Primary Victory Institutional Interest in Ford Stock Surges on Unusual LongTerm Call Options Activity SXI Q1 2026 Earnings Modest EPS Miss Amidst Solid Operational Performance AMR Q1 2026 Earnings Significant Earnings Miss Amid Challenging Conditions DHI Group DHX Q1 2026 Earnings EPS Surges 164 Above Estimates Shares Rise MRK Q1 2026 Earnings EPS Surprise on a Loss Stock Declines 22 CorVel Corp CRVL Q1 2026 Earnings EPS of 061 Reported Stock Edges Higher GPGI Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Declines Northern Oil and Gas NOG Edges Higher Amid Energy Sector Volatility Array Digital Infrastructure Notes UZE Edge Lower as Yield Concerns Persist Community Health Systems CYH Holds at 280 Following Modest Uptick Intrepid Potash Inc IPI Inches Higher Approaches Key Technical Resistance at 4176 Western Asset High Income Fund II HIX Edges Lower as Yield Seekers Navigate Bond Market Uncertainty Nostalgia and Speculation Fuel MultiMillion Dollar Pokmon Card Market TRNR Q1 2026 Earnings EPS Beats Estimates Despite No Revenue Stock Falls 1254 Rezolute RZLT Edges Higher Key Levels to Watch After 108 Gain JJSF Q1 2026 Earnings EPS Misses Estimates Despite Narrow Surprise Stock Edges Higher WSBCO Q1 2026 Earnings Preferred EPS Surpasses Estimates by 321 APOS Q1 2026 Earnings Apollo Global Management Reports Slight EPS Miss Revenue Not Disclosed INVO Fertility Inc IVF Q3 2025 Earnings Significant EPS Miss No Revenue Reported HLI Q1 2026 Earnings EPS Misses Estimates Amid Modest Stock Uptick NVTS Q1 2026 Earnings Narrowed Loss Surpasses Estimates Shares Rally Nearly 20 ZBIO Q1 2026 Earnings NarrowerThanExpected Loss as PreRevenue Biotech Advances Pipeline